
REGENPRP™-HA COMBINATION : Facial appearance
Hersant B. et al | Micheels P.A significant breakthrough in facial rejuvenation has been highlighted in a prospective study published in the Journal of the American Academy of Dermatology in 2017. Conducted by Hersant et al., the research investigated the efficacy of combining autologous platelet-rich plasma (PRP) with hyaluronic acid (HA) for enhancing skin rejuvenation.
Significant improvement in skin elasticity.
In a prospective study, 31 patients were treated by mesotherapy with the RegenPRP® and HA combination prepared with RegenPRP®-HA at 0, 1, and 2 months. Clinical benefits were evaluated by FACE-Q scores and biophysical measurements of skin elasticity.
Comparison of FACE-Q scores showed significant improvement at 6 months compared with baseline (p=0.03). Similarly, objective biophysical measurements showed significant improvement in skin elasticity (R5) compared to baseline (p=0.036) at 6 months post-treatment.
No serious side effects were reported.
The study underscores the importance of combining PRP and hyaluronic acid to achieve optimal outcomes in aesthetic medicine. It also reinforces the trend towards using autologous and biocompatible therapies, aligning with modern patients’ preference for safe and effective solutions.
For more information about this innovative approach or to learn how to incorporate this technique into your practice, feel free to contact us or explore our regenerative and aesthetic solutions.
REFERENCE
- Hersant et al. Efficacy of autologous platelet-rich plasma combined with hyaluronic acid on skin facial rejuvenation: A prospective study. J Am Acad Dermatol 2017;77(3):584–6
- Micheels De l’intérêt de la combinaison « acide hyaluronique + plasma riche en plaquettes » en mésothérapie esthétique. AFME 2017. www.afme.org/corps/autres-corps/ combinaison-acide-hyaluronique-et-prp/ (accessed October 15, 2020).